4 ePosters
Session Name- SaaG e-Posters: Novel risk factors, biomarkers, and anti-inflammatory therapies
Filtered By
- SaaG e-Posters: Novel risk factors, biomarkers, and anti-inflammatory therapies
Sort By
3. DYSLIPIDEMIA AND RISK FACTORS || 3.8 Novel risk factors and biomarkers
131 - Increased gene expression of resistin and CD36 in peripheral blood mononuclear cells is associated with hypercholesterolemia in patients with obstructive sleep apnea (ID 115)
Session Name
SaaG e-Posters: Novel risk factors, biomarkers, and anti-inflammatory therapies
Presentation Topic
3.8 Novel risk factors and biomarkers
Presenter
132 - GlycA as a biomarker of inflammation and subclinical atherosclerosis in very early rheumatoid arthritis (ID 556)
Session Name
SaaG e-Posters: Novel risk factors, biomarkers, and anti-inflammatory therapies
Presentation Topic
3.8 Novel risk factors and biomarkers
Presenter
133 - New insights into the molecular mechanisms underlying the pro-atherosclerotic and vasculo-toxic effect of iron (ID 1065)
Session Name
SaaG e-Posters: Novel risk factors, biomarkers, and anti-inflammatory therapies
Presentation Topic
3.8 Novel risk factors and biomarkers
Authors
- Francesca Vinchi, United States of America
- Graca Porto, Portugal
- Andreas Simmelbauer, Germany
- Sandro Altamura, Germany
- Maciej Garbowski, United Kingdom
- André M. N. Silva, Portugal
- Sebastian Spaich, Germany
- Svenja E. Seide, Germany
- Richard Sparla, Germany
- Matthias W. Hentze, Germany
- Martina U. Muckenthaler, Germany
4. CLINICAL VASCULAR DISEASE || 4.11 Anti-inflammatory therapies
134 - Development of nanocapsules vectorized with Anti-Pecam-1 containing the anti-inflammatory docosohexaenoic acid as cotherapy to promote atherosclerosis regression (ID 37)
Session Name
SaaG e-Posters: Novel risk factors, biomarkers, and anti-inflammatory therapies
Presentation Topic
4.11 Anti-inflammatory therapies
Presenter